Emilio López-Millán , Janet A. Gutiérrez-Uribe , Marilena Antunes-Ricardo
{"title":"Omega-3 supplementation: Impact on low chronic inflammation associated with obesity","authors":"Emilio López-Millán , Janet A. Gutiérrez-Uribe , Marilena Antunes-Ricardo","doi":"10.1016/j.tifs.2024.104799","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Supplementation of Omega-3 polyunsaturated fatty acids (PUFA), mainly alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), has been associated with beneficial effects on inflammatory processes resulting from overweight or obesity. Omega-3-PUFA commonly obtained through fish, seeds, or nuts, reduces or modulates the expression of inflammatory mediators. Despite their benefits, fish-derived products are poorly accepted, leading to omega-3 consumption deficiency.</div></div><div><h3>Scope and approach</h3><div>This work aimed to evaluate the effects associated with omega-3-PUFA supplementation in models of overweight and/or obesity, focusing on the change in inflammation-related markers. Three groups were analyzed: <em>ex vivo</em> and <em>in vivo</em> models, and clinical trials. Inflammatory and metabolic markers, as well as transcriptomic activity modulated by omega-3, were detailed based on the source, frequency, and dosage. Likewise, different strategies for the incorporation of omega-3 in the design of new food to increase its consumption were analyzed.</div></div><div><h3>Key findings and conclusions</h3><div>Omega-3-PUFA supplementation is strongly correlated to a decrease in inflammatory markers in blood and adipose tissue, including interleukin 18 (IL-18), interleukin 6 (IL-6), tumor necrosis factor-α, (TNF-α), intracellular adhesion molecule 1 (ICAM-1), monocyte chemoattractant protein 1 (MCP1), c-reactive protein (CRP), and CX3CL1. Omega-3 can regulate the NLRP3 inflammasome activation in adipocytes and promote anti-inflammatory adipokine production. Blood triglycerides and cholesterol levels in patients affected by overweight or associated comorbidities were reduced after omega-3 supplementation. Omega-3 supplementation has demonstrated promising results in modulating low-grade chronic inflammation associated with overweight or obesity. Continuous strategies to enrich products with omega-3 are necessary to promote an increased omega-3 intake.</div></div>","PeriodicalId":441,"journal":{"name":"Trends in Food Science & Technology","volume":"155 ","pages":"Article 104799"},"PeriodicalIF":15.1000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Food Science & Technology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0924224424004758","RegionNum":1,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"FOOD SCIENCE & TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Supplementation of Omega-3 polyunsaturated fatty acids (PUFA), mainly alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), has been associated with beneficial effects on inflammatory processes resulting from overweight or obesity. Omega-3-PUFA commonly obtained through fish, seeds, or nuts, reduces or modulates the expression of inflammatory mediators. Despite their benefits, fish-derived products are poorly accepted, leading to omega-3 consumption deficiency.
Scope and approach
This work aimed to evaluate the effects associated with omega-3-PUFA supplementation in models of overweight and/or obesity, focusing on the change in inflammation-related markers. Three groups were analyzed: ex vivo and in vivo models, and clinical trials. Inflammatory and metabolic markers, as well as transcriptomic activity modulated by omega-3, were detailed based on the source, frequency, and dosage. Likewise, different strategies for the incorporation of omega-3 in the design of new food to increase its consumption were analyzed.
Key findings and conclusions
Omega-3-PUFA supplementation is strongly correlated to a decrease in inflammatory markers in blood and adipose tissue, including interleukin 18 (IL-18), interleukin 6 (IL-6), tumor necrosis factor-α, (TNF-α), intracellular adhesion molecule 1 (ICAM-1), monocyte chemoattractant protein 1 (MCP1), c-reactive protein (CRP), and CX3CL1. Omega-3 can regulate the NLRP3 inflammasome activation in adipocytes and promote anti-inflammatory adipokine production. Blood triglycerides and cholesterol levels in patients affected by overweight or associated comorbidities were reduced after omega-3 supplementation. Omega-3 supplementation has demonstrated promising results in modulating low-grade chronic inflammation associated with overweight or obesity. Continuous strategies to enrich products with omega-3 are necessary to promote an increased omega-3 intake.
期刊介绍:
Trends in Food Science & Technology is a prestigious international journal that specializes in peer-reviewed articles covering the latest advancements in technology, food science, and human nutrition. It serves as a bridge between specialized primary journals and general trade magazines, providing readable and scientifically rigorous reviews and commentaries on current research developments and their potential applications in the food industry.
Unlike traditional journals, Trends in Food Science & Technology does not publish original research papers. Instead, it focuses on critical and comprehensive reviews to offer valuable insights for professionals in the field. By bringing together cutting-edge research and industry applications, this journal plays a vital role in disseminating knowledge and facilitating advancements in the food science and technology sector.